Search research articles
Contact Us
Filters
Showing results (241-250 of 252) with videos related to
Page
of 26
Sort By:
Journal of Medicinal Chemistry
|
April 1, 1987
Substituted 1,2,3,4-tetrahydroaminonaphthols: antihypertensive agents, calcium channel blockers, and adrenergic receptor blockers with catecholamine-depleting effects
K S Atwal, B C O'Reilly, E P Ruby, et al.
Journal of Cardiovascular Pharmacology
|
December 30, 1998
Chronic dual inhibition of angiotensin-converting enzyme and neutral endopeptidase during the development of left ventricular dysfunction in dogs
C V Thomas, G M McDaniel, H H Holzgrefe, et al.
Journal of Medicinal Chemistry
|
June 1, 1988
Angiotensin-converting enzyme inhibitors. Mercaptan, carboxyalkyl dipeptide, and phosphinic acid inhibitors incorporating 4-substituted prolines
J Krapcho, C Turk, D W Cushman, et al.
Journal of Clinical Periodontology
|
January 1, 1992
Interleukin-1 beta (IL-1 beta) levels in gingival crevicular fluid from adults with previous evidence of destructive periodontitis. A cross sectional study
J M Wilton, J L Bampton, G S Griffiths, et al.
Journal of Medicinal Chemistry
|
January 1, 1988
(Phosphinyloxy)acyl amino acid inhibitors of angiotensin converting enzyme (ACE). 1. Discovery of (S)-1-[6-amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-L -proline a novel orally active inhibitor of ACE
D S Karanewsky, M C Badia, D W Cushman, et al.
Pharmacotherapy
|
November 1, 1995
Comparison of quantitative methods to assess hepatic function: Pugh's classification, indocyanine green, antipyrine, and dextromethorphan
W D Figg, G E Dukes, H R Lesesne, et al.
British Journal of Pharmacology
|
September 1, 1994
BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174
K E Dickinson, R B Cohen, S Skwish, et al.
Journal of Clinical Pharmacology
|
March 1, 1996
Pharmacokinetics of ondansetron in patients with hepatic insufficiency
W D Figg, G E Dukes, J F Pritchard, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
May 20, 2026
Hippocampal Dosimetry and Implication for Treatment Planning in Patients Undergoing Stereotactic Radiosurgery for Limited Brain Metastases
N S Iqbal, M C Williams, M G J Williams, et al.
Journal of the American College of Cardiology
|
November 20, 1998
The effects of endothelin-A receptor blockade during the progression of pacing-induced congestive heart failure
D Saad, R Mukherjee, P B Thomas, et al.
Page
of 26
Search research articles
Search
Showing results (241-250 of 252) with videos related to
Sort By:
Page
of 26
Journal of Medicinal Chemistry
|
April 1, 1987
Substituted 1,2,3,4-tetrahydroaminonaphthols: antihypertensive agents, calcium channel blockers, and adrenergic receptor blockers with catecholamine-depleting effects
K S Atwal, B C O'Reilly, E P Ruby, et al.
Journal of Cardiovascular Pharmacology
|
December 30, 1998
Chronic dual inhibition of angiotensin-converting enzyme and neutral endopeptidase during the development of left ventricular dysfunction in dogs
C V Thomas, G M McDaniel, H H Holzgrefe, et al.
Journal of Medicinal Chemistry
|
June 1, 1988
Angiotensin-converting enzyme inhibitors. Mercaptan, carboxyalkyl dipeptide, and phosphinic acid inhibitors incorporating 4-substituted prolines
J Krapcho, C Turk, D W Cushman, et al.
Journal of Clinical Periodontology
|
January 1, 1992
Interleukin-1 beta (IL-1 beta) levels in gingival crevicular fluid from adults with previous evidence of destructive periodontitis. A cross sectional study
J M Wilton, J L Bampton, G S Griffiths, et al.
Journal of Medicinal Chemistry
|
January 1, 1988
(Phosphinyloxy)acyl amino acid inhibitors of angiotensin converting enzyme (ACE). 1. Discovery of (S)-1-[6-amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-L -proline a novel orally active inhibitor of ACE
D S Karanewsky, M C Badia, D W Cushman, et al.
Pharmacotherapy
|
November 1, 1995
Comparison of quantitative methods to assess hepatic function: Pugh's classification, indocyanine green, antipyrine, and dextromethorphan
W D Figg, G E Dukes, H R Lesesne, et al.
British Journal of Pharmacology
|
September 1, 1994
BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174
K E Dickinson, R B Cohen, S Skwish, et al.
Journal of Clinical Pharmacology
|
March 1, 1996
Pharmacokinetics of ondansetron in patients with hepatic insufficiency
W D Figg, G E Dukes, J F Pritchard, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
May 20, 2026
Hippocampal Dosimetry and Implication for Treatment Planning in Patients Undergoing Stereotactic Radiosurgery for Limited Brain Metastases
N S Iqbal, M C Williams, M G J Williams, et al.
Journal of the American College of Cardiology
|
November 20, 1998
The effects of endothelin-A receptor blockade during the progression of pacing-induced congestive heart failure
D Saad, R Mukherjee, P B Thomas, et al.
Page
of 26